Vol. 13.Issue. 5. September - October 2014 | Annals of Hepatology

¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta

* = Required fields

Enter your email address

User name *

Annals of Hepatology

Buscar en

Annals of Hepatology

Toda la web

Inicio Annals of Hepatology

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Web of Science, Medline/PubMed, DOAJ and Conacyt

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more

Impact factor 2022

3.8

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2022

6.3

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2022

0.859

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2022

0.989

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Vol. 13. Issue 5.

Pages 480-711 (September - October 2014)

Hepatology highlights

Hepatology highlights

Giorgio Bedogni, Claudio Tiribelli

Ann Hepatol. 2014;13:480-1

Open access

Concise review

Probiotics and synbiotics may improve liver aminotransferases levels in non-alcoholic fatty liver disease patients

Caroline Buss, Cristiane Valle-Tovo, Suellen Miozzo, Angelo Alves de Mattos

Ann Hepatol. 2014;13:482-8

Open access

Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease

Zhang Wenfeng, Wu Yakun, Mu Di, Gong Jianping, Wu Chuanxin, Huang Chun

Ann Hepatol. 2014;13:489-95

Open access

Original article

Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina

María S. Munné, Nancy R. Altabert, Lucio O. Otegui M., Sara N. Vladimirsky, Rita Moreiro, María P. Espul, Carlos Espul, Abelardo Manzur, ... Jorge E. González

Ann Hepatol. 2014;13:496-502

Open access

Treatment of chronic hepatitis C genotype 1 early responders with 36 week pegylated interferon and ribavirin therapy

Ajit Sood, Vandana Midha, Omesh Goyal

Ann Hepatol. 2014;13:503-9

Open access

Hepatitis E virus exposure in pregnant women in rural Durango, Mexico

Cosme Alvarado-Esquivel, Luis F. Sánchez-Anguiano, Jesús Hernández-Tinoco

Ann Hepatol. 2014;13:510-7

Open access

Promotor methylation: Does it affect response to therapy in chronic hepatitis C (G4) or fibrosis?

Abdel-Rahman N. Zekri, Ahmed M. Raafat, Suzan Elmasry, Abeer A. Bahnassy, Yasmin Saad, Hamed A. Dabaon, Mohamed El-Kassas, Hend I. Shousha, ... Nehal Hussein

Ann Hepatol. 2014;13:518-24

Open access

Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experience

Nabiha Faisal, Eric M. Yoshida, Marc Bilodeau, Philip Wong, Mang Ma, Kelly W. Burak, Bandar Al-Judaibi, Eberhard L. Renner, Leslie B. Lilly

Ann Hepatol. 2014;13:525-32

Open access

Survey of health status, nutrition and geography of food selection of chronic liver disease patients

Timothy Leslie, Lisa Pawloski, Jillian Kallman-Price, Carey Escheik, Noreen Hossain, Yun Fang, Lynn H. Gerber, Zobair M. Younossi

Ann Hepatol. 2014;13:533-40

Open access

Ultra-sensitive procalcitonin may help rule out bacterial infections in patients with cirrhosis

Sebastián Marciano, Leila Haddad, Alfredo P. Martínez, María L. Posadas, Federico Piñero, Gonzalo J. Mora, Laura N. Guerrero, Ezequiel Ridruejo, ... Adrián C. Gadano

Ann Hepatol. 2014;13:541-7

Open access

Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis & correlates with poor clinical outcomes

Karlyn Martin, Leila Kia, Neehar D. Parikh, Laura Kulik, Brandon McMahon

Ann Hepatol. 2014;13:548-54

Open access

Images in hepatology

Embolization of porto-systemic shunt as treatment for recurrent hepatic encephalopathy

Hugh Leonard, James O’Beirne, Dominic Yu, Emmanuel Tsochatzis

Ann Hepatol. 2014;13:555-7

Open access

Case report

Minimally invasive treatment of Mirizzi’s syndrome: is there a safe way? Report of a case series

Giuseppe Piccinni, Andrea Sciusco, Giuseppe Massimiliano De Luca, Angela Gurrado, Alessandro Pasculli, Mario Testini

Ann Hepatol. 2014;13:558-64

Open access

Antimitochondrial antibody serocoversion post-liver transplant during hepatitis C treatment with peginterferon α, ribavirin and telaprevir

Vladimir Marquez-Azalgara, Trana Hussaini, Siegfried R. Erb, Eric M. Yoshida

Ann Hepatol. 2014;13:565-7

Open access

Juvenile hemochromatosis associated with heterozygosity for novel hemojuvelin mutations and with unknown cofactors

Serena Pelusi, Raffaela Rametta, Claudia Della Corte, Riccardo Congia, Paola Dongiovanni, Edoardo A. Pulixi, Silvia Fargion, Anna L. Fracanzani, ... Luca Valenti

Ann Hepatol. 2014;13:568-71

Open access

Letter to editor

Mean platelet volume: a useful predictor of ascitic fluid infection in cirrhotic patients?

Alpaslan Tanoglu, Ergenekon Karagöz

Ann Hepatol. 2014;13:572

Open access

Mean platelet volume is a useful indicator of systemic inflammation in cirrhotic patients with ascitic fluid infection

Burak Suvak, Serkan Torun, Adnan Tas, Yavuz Beyazit

Ann Hepatol. 2014;13:573

Open access

Liver news elsewhere

The good, the bad and the ugly of the new treatments for hepatitis C virus

Karen V. Silva-Vidal, Nahum Méndez-Sánchez

Ann Hepatol. 2014;13:574-5

Open access

Index section

XXIII Annual Meeting of the Latin American Association for the Study of the Liver and the National Congress of the Mexican Association of Hepatology. Index Section

Ann Hepatol. 2014;13:577-600

Open access

Abstract section

XXIII Annual Meeting of the Latin American Association for the Study of the Liver and the National Congress of the Mexican Association of Hepatology. Abstract Section-Oral Presentations

Ann Hepatol. 2014;13:601-20

Open access

XXIII Annual Meeting of the Latin American Association for the Study of the Liver and the National Congress of the Mexican Association of Hepatology. Abstract Section-Poster Presentations

Ann Hepatol. 2014;13:621-711

Open access